InfoErbe

Kava kava

Piper methysticum G. Forster

Wed, 04 May 2005 20:18:57 +0200

Bibliografia

  • Anon (1983) British Herbal Pharmacopeia. Keighley: British Herbal Medicine Association
  • Backhauss C Krieglstein J (1992) Extract of kava (Piper methysticum) and its methysticin constituents protect brain tissue against ischemic damage in rodents. Eur J Pharmacol 215(2-3):265-9
  • BAH (2001) 'Summary translation of section describing the cases in “Draft statement of two German pharmaceutical associations, Bundersverband der Arzneimittel Herstell e. V. (BAH) and Bunderverband der Pharmazeutischen Indusctrie e. V. ( BPI)” summary translation' di Angela Grunwald per il TMEC
  • Barguil Y. (2001) “Kava and gamma-glutamyltransferase increase: hepatic enzymatic induction or liver function alteration.” Electronic letter published http:/bmj.com 21 March 2001 in response to Escher M, Desmeules J, Giostra E et al. Drug points: Hepatitis associated with kava, a herbal remedy for anxiety. BMJ; 322: 139.
  • Boonen G, Haberlein H (1998) Influence of genuine kavapyrone enantiomers on the GABA-A binding site.Planta Med ;64(6):504-6
  • Chanwai, L., (2000) 'Kava toxicity.' Emergency Medicine 12, 142-145
  • Cheng D Lidgard RO Duffield PH Duffield AM Brophy JJ (1988) Identification by methane chemical ionization gas chromatography/mass spectrometry of the products obtained by steam distillation and aqueous acid extraction of commercial Piper methysticum. Biomed Environ Mass Spectrom 17(5):371-6
  • Clough, A., et al. (2000) 'Kava in Arnhem Land: a review of consumption and its social correlates'. Drugs and Alcohol Review 19(3), 319-323
  • d'Abbs P, Burns C. (1997) “Draft report on inquiry into the issue of kava regulation.” [Prepared for the Sessional Committee on the Use and Abuse of Alcohol by the Community.] Menzies School of Health Research, Darwin.
  • Davies LP Drew CA Duffield P Johnston GA Jamieson DD (1992) Kava pyrones and resin: studies on GABAA, GABAB and benzodiazepine binding sites in rodent brain. Pharmacol Toxicol 71(2):120-6
  • De Leo, V., et al., (2001) 'Evaluation of combining kava extract with hormone replacement therapy in the treatment of postmenopausal anxiety'. Maturitas 39, 185-188
  • Duffield AM Jamieson DD Lidgard RO Duffield PH Bourne DJ (1989) Identification of some human urinary metabolites of the intoxicating beverage kava. J Chromatogr 475:273-81
  • Duffield PH Jamieson DD Duffield AM (1989) Effect of aqueous and lipid-soluble extracts of kava on the conditioned avoidance response in rats. Arch Int Pharmacodyn Ther 301:81-90
  • Ellingwood, F. (1919) American Materia Medica, Therapeutics and Pharmacognosy. Reprinted by Oregon: Ec;lectic Medical Publications
  • Felter, H., Lloyd, J. (1903) reprinted 1983. King's American dispensatory. Portland: Eclectic Medical Publications
  • German Commission E (1990) “Piperis methystici rhizoma (Kava-Kava-Wurzelstock). German Commission E Monograph” Bundesanzeiger , 101 (1)
  • Gleitz J Beile A Peters T (1995) (+/-)-Kavain inhibits veratridine-activated voltage-dependent Na(+)- channels in synaptosomes prepared from rat cerebral cortex. Neuropharmacology 34(9):1133-8
  • Gleitz J Friese J Beile A Ameri A Peters T (1996) Anticonvulsive action of (+/-)-kavain estimated from its properties on stimulated synaptosomes and Na+ channel receptor sites. Eur J Pharmacol 315(1):89-97
  • Gleitz J, Beile A, Wilkens P, Ameri A, Peters T (1997) Antithrombotic action of the kava pyrone (+)-kavain prepared from Piper methysticum on human platelets. Planta Med;63(1):27-30
  • Greenwood-Robinson, M. (1999) Kava. Dell Publishing
  • Grunze H, et al. (2001) 'Kava pyrones exert effects on neuronal transmission and transmembraneous cation currents similar to established mood stabilizers--a review'. Prog Neuropsychopharmacol Biol Psychiatry 25(8), 1555-70
  • Haberlein, H., et al., (1997) 'Piper methysticum: enantiomeric separation of kavapyrones by HPLC'. Planta Medica 63, 63-65
  • Hänsel R, Keller K, Rimpler H and Schneider G (eds.) (1994) Hagers Handbuch der Pharmazeutischen Praxis, 5th ed. Volume 6: Drogen P-Z. Berlin-Heidelberg-New York-London: Springer-Verlag:191-221
  • He, X, et al., (1997) 'Electrospray HPLC-MS in phytochemical analysis of Kava (Piper methysticum) extract.' Planta Medica 63, 70-74
  • Hope BE Massey DG Fournier-Massey G (1993) Hawaiian materia medica for asthma. Hawaii Med J 52(6):160-6
  • Jamieson DD Duffield PH Cheng D Duffield AM (1989) Comparison of the central nervous system activity of the aqueous and lipid extract of kava (Piper methysticum). Arch Int Pharmacodyn Ther 301:66-80
  • Jamieson DD, Duffield PH. (1990) “Positive interaction of ethanol and kava resin in mice. Clin Exp Pharmacol Physiol.; 17(7): 509-14
  • Johnson, T. (1999) CRC ethnobotany desk reference. Florida: CRC Press
  • Jussofie A Schmiz A Hiemke C (1994) Kavapyrone enriched extract from Piper methysticum as modulator of the GABA binding site in different regions of rat brain. Psychopharmacology (Berl) 116(4):469-74
  • Kinzler E, Kromer J, Lehmann E. (1991) Effect of a special kava extract in patients with anxiety-, tension, and excitation states of non-psychotic genesis. Double blind study with placebos over four weeks [in German]. Arzneimforsch.;41:584-588.
  • Langosch JM, Normann C, Schirrmacher K, Berger M, Walden J (1998) The influence of (+/-)-kavain on population spikes and long-term potentiation in guinea pig hippocampal slices; Comp Biochem Physiol A Mol Integr 120(3):545-9
  • Lebot V and Levesque J. (1996) “Genetic control of kavalactone chemotypes in Piper methysticum cultivars.” Phytochemistry, 43, 397-403.
  • Lebot, V., et al., (1997) Kava - the Pacific Elixir. Vermont: Healing Arts Press
  • Lehmann E, et al. (1996) Efficacy of special kava extract (Piper methysticum) in patients with states of anxiety, tension and excitedness of non-mental origin-A double blind placebo controlled study of four weeks treatment. Phytomedicine.;3:113-119.
  • Lindenberg Von D, Pitule-Schodel H. D (1990) L-Kavain in comparison with oxazepam in anxiety states. Double-blind clinical trial. Forschr Med.;108:50-54.
  • Locher CP Burch MT Mower HF Berestecky J Davis H Van Poel B Lasure A (1995) Vanden Berghe DA Vlietinck AJ Anti-microbial activity and anti-complement activity of extracts obtained from selected Hawaiian medicinal plants. J Ethnopharmacol 49(1):23-32
  • Mathews JD, Riley MD, Fejo L et al. (1988) “Effects of the heavy usage of kava on physical health: summary of a pilot survey in an Aboriginal community.” Med J Aust; 148: 548-555
  • Mills, S., Bone, K., (2000) Principles and Practice of Phytotherapy Edinburgh: Churchill Livingstone
  • Ministero della Salute, Ufficio XII, Direzione generale della sanità pubblica, veterinaria, alimenti e nutrizione. (2002) Circolare 22/1/2002 - 600.12/Ag 45.1/221
  • Munte TF Heinze HJ Matzke M Steitz J (1993) Effects of oxazepam and an extract of kava roots (Piper methysticum) on event-related potentials in a word recognition task. Neuropsychobiology 27(1):46-53
  • Norton SA, Ruze P. (1994) “Kava dermopathy.” J. Amer. Acad. Dermatol., 31, 89-97
  • Nowakowska E, Ostrowicz A, Chodera A (1998) [Kava-kava preparations--alternative anxiolytics].Pol Merkuriusz Lek;4(21):179-180a
  • Pittler, M., Ernst, E., (2000) 'Efficacy of Kava Extract for Treating Anxiety: Systematic Review and Meta-Analysis'. Journal of Clinical Psychopharmacology 20(1), 84-89
  • Rote Liste Service GmbH (edas.) (2001) “Psychopharmaka (Section 71).” Rote Liste 2001 Arzneimittelverzeichnis für Deutschland (einschließlich EU-Zulassungen und estimmter Medizinprodukte. Editio Cantor Verlag,.
  • Russmann S, Lauterburg BH, Helbling A. (2001) “Kava hepatotoxicity.” Ann Intern Med; 135(1): 68-69
  • Schirrmacher K, Busselberg D, Langosch JM, Walden J, Winter U, Bingmann D (1999) Effects of (+/-)-kavain on voltage-activated inward currents of dorsal root ganglion cells from neonatal rats. Eur Neuropsychopharmacol ;9(1-2):171-6
  • Schmidt P, Boehncke W-H. (2000) “Delayed-type hypersensitivity reaction to kava-kava extract. Contact Dermatitis;42:363-4.
  • Schmidt P. (2000) “Lebernebenwirkungen durch Kava-Extrakt.” Journal für Orthomolecular Medizin 9(4):379-391
  • Schmitz D Zhang CL Chatterjee SS Heinemann U (1995) Effects of methysticin on three different models of seizure like events studied in rat hippocampal and entorhinal cortex slices. Naunyn Schmiedebergs Arch Pharmacol 351(4):348-55
  • Schulz, V., et al. (1997) Rational phytotherapy. Heidelberg: Springer-Verlag
  • Seitz U, Ameri A, Pelzer H, Gleitz J, Peters T (1997) Planta Med ;63(4):303-6 Relaxation of evoked contractile activity of isolated guinea-pig ileum by (+/-)-kavain.
  • Singh YN (1992) Kava: an overview. J Ethnopharmacol 37(1):13-45
  • Spinella, M. (2001) The Psychopharmacology of Herbal Medicine. Massachusetts: MIT Press
  • Steiner GG. (2000) “The correlation between cancer incidence and kava consumption.” Hawaii Med J ; 59: 420-422
  • Stoller R. (2000) “Leberschadigungen unter kava-extrakten.” Schweizerische Arztezeitung; 81(24): 1335-1336
  • Uebelhack R, Franke L, Schewe HJ (1998) Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava).; Pharmacopsychiatry 31(5):187-92
  • Volz HP, Kieser M. (1997) Kava-kava extract WS 1490 versus placebo in anxiety disorders-a randomized placebo-controlled 25-week outpatient trial. Pharmacopsychiatry.;30:1-5.
  • Walden J, von Wegerer J, Winter U, Berger M, Grunze H (1997) Effects of kawain and dihydromethysticin on field potential changes in the hippocampus. Prog Neuropsychopharmacol Biol Psychiatry ;21(4):697-706
  • Warnecke G. (1991) Psychosomatic dysfunction in the female climacteric. Clinical effectiveness and tolerance of kava extract WS 1490 [in German]. Fortschr Med. 109:119-122.
  • Whitton, P., et al. (2002) In via di pubblicazione. Vedi sito EHPA www.users.globalnet.co.uk/~ehpa/
Wed, 04 May 2005 20:18:57 +0200

Licenza Creative Commons
Il database InfoErbe
è pubblicato con
Licenza Creative Commons

Marco Valussi
Luciano Posani

Copyright 2000 - 2005 Miro International Pty Ltd. All rights reserved. Mambo is Free Software released under the GNU/GPL License.